Metro Vein Centers Realized Investment

Value Creation

+ 200% Revenue Growth

+ 200% EBITDA Growth

Expanded executive suite to include individuals with experience in multisite and healthcare, including CEO (former Starwood, IHG) and COO (former Stericyle)

Expanded footprint from five to 13 centers through new build openings in three new states

Centralized back-office operations including call center, billing, finance, and clinical compliance

Developed new service lines including treatments for central venous disease

Shifted advertisement budget to digital, reducing customer acquisition cost (“CAC”) by 35%

Shifted new patient mix from 5% to 15% referrals, reducing CAC by 10%